The 11th Chongyang Endocrinology and Metabolism Summit was successfully held
The 11th Chongyang Endocrinology and Metabolism Summit (referred to as "Chongyang Summit"), sponsored by the Chinese Geriatric Society and hosted by the Endocrinology and Metabolism Branch of the Chinese Geriatric Society, was successfully held online from October 17 to 18, 2020. The conference invited leading experts in the field of endocrinology and metabolism in the country to give speeches, and carried out various forms of academic activities in the field of endocrinology and metabolism, especially in the field of elderly endocrinology and metabolism related research hotspots and important issues of concern to the majority of physicians, providing a platform for participants to display and exchange different academic views, and contributing to the development of endocrine and metabolism in China.
Cloud opening documentary: All the past, are the prologue
The opening ceremony was presided over by Professor Tian Hui, former president of Endocrinology and Metabolism Branch of Chinese Geriatric Society and geriatric Endocrinology Department of Chinese People's Liberation Army General Hospital. Professor Tian pointed out that the Endocrine metabolism branch of the Chinese Geriatric Society has completed the election, approved by the General Association, Professor Tian Hui served as honorary president, and the second president was Professor Lv Xiaofeng, Endocrinology Department of the Seventh Medical Center of the Chinese People's Liberation Army General Hospital. Professor Tian said that the purpose of the establishment of Chongyang Endocrinology and Metabolism Summit is to base on the health cause of the elderly, promote the development of the medical education and research cause of the elderly endocrinology and metabolism, transmit the advanced information of the global profession, establish the management concept and strategy of the elderly Xie disease with Chinese characteristics, and improve the management level of the elderly endocrine and metabolism diseases in the country. I believe that under the leadership of Professor Lu, the Endocrinology and Metabolism branch of the Chinese Geriatric Society will do better and better work.
In the new president's speech, Professor Lu said that 2020 is an extraordinary year, China has achieved a great victory in the fight against the novel coronavirus epidemic, and all achievements have attracted the attention of the world. Chinese people's living standards continue to improve, people's demand for health is gradually increasing, China's aging and elderly population is growing rapidly, and the threat and trouble of chronic diseases for the elderly is increasing. Among them, endocrine and metabolic diseases are particularly serious. In the past 10 years, under the leadership of President Tian Hui, the Endocrinology and Metabolism Branch of the Chinese Geriatric Society has done a lot of work. For example, the annual Chongyang Endocrine Metabolism Summit has formed a brand; Organized and carried out research on the status quo of elderly diabetes management with outstanding achievements; The Expert Consensus on the Diagnosis and Treatment of Type 2 Diabetes in Elderly People in China has been widely recognized. The Branch of Endocrinology and Metabolism has gradually grown and become an important academic organization for geriatric medicine in China. Here, we would like to express our sincere thanks to Director Tian for his hard work. In the future, Professor Lu will also work together with everyone to follow the national guidelines, policies, laws and regulations on health care for the elderly and the elderly service industry, uphold the guidelines of the Association on promoting the development of geriatric medicine, and continue to make progress in the management and service of health promotion for the elderly.
This meeting invited many well-known domestic experts to interpret their insights, and thank you for bringing the academic meal of endocrinology and metabolism medicine for the elderly. At the same time, I also thank every member for their positive contributions to the society, and thank the older generation of experts for their conscientious and selfless dedication, they will always be our role models. I would like to thank all the speakers, all the members of the conference team for their hard work, and all the leaders for their support and encouragement.
New President Interview: Focus on elderly patients, overview of the conference highlights
During the meeting, "International Diabetes" interviewed the new president Professor Xiaofeng Lv about the highlights of the meeting, the precautions for disease management in elderly patients, and the application of insulin pumps.
u 2020 Double Ninth meeting highlights analysis
As a conference hosted by the Endocrinology and Metabolism Branch of the Chinese Geriatric Society, the Chongyang Endocrinology and Metabolism Summit mainly focuses on the field of elderly endocrine diseases. This year's content arrangement mainly covers three aspects:
First, basic research and basic treatment of diabetes. The morning speaker introduced basic research on islet cells, evaluation of islet function, and a series of studies on insulin resistance (ADA Banting Award), which combined basic research and clinical application in a simple way. Lively presentations by Canadian and domestic professors on exercise therapy and diet therapy for diabetes further enhanced participants' awareness of the importance and operability of these two basic treatments for diabetes.
Second, based on the nature of the society, the content of the conference is not limited to diabetes, but also focuses on other endocrine diseases of the elderly. It should be especially emphasized that regardless of diabetes or other diseases, the target value control of elderly patients is different from that of young people, and individual goals need to be formulated according to the characteristics of patients. The decline of age-related organ function in the elderly determines the particularity of drug use. In addition, the elderly may be complicated by many other diseases, and the interaction of multiple drugs should be considered when using drugs. In addition, the meeting also focused on thyroid diseases, osteoporosis, hyperuricemia and other issues.
Third, unlike in previous years, this year there is a half day dedicated to introducing the application of new technologies in the elderly. There are two core technologies in the field of endocrinology - insulin pumps and dynamic blood glucose monitoring. Insulin pump hypoglycemic effect is accurate, can reduce hypoglycemia, suitable for the elderly application. The application of dynamic blood glucose monitoring in the elderly should be more and more extensive. Because the elderly are prone to hypoglycemia, dynamic blood glucose monitoring can monitor a patient's blood glucose profile and understand when hypoglycemia occurs, especially at night. The new device has an alarm function, which is a good way to prevent hypoglycemia in the elderly. Preventing hypoglycemia in older adults is important because a single bout of severe hypoglycemia can undo a lifetime of good blood sugar control.
u The particularity of disease management in elderly patients
Whether it is diabetes or thyroid disease, the incidence of elderly people is relatively high. Elderly patients with diabetes are often complicated with many diseases such as cardiovascular and cerebrovascular diseases, and the disability rate and fatality rate are high. In addition, the heterogeneity of the elderly is also large. The most important point is that the organ function of the elderly, especially the liver and kidney function, gradually declines, and drug metabolism changes, which brings a lot of problems that need to be paid attention to in clinical treatment.
First, the kidney function of the elderly is significantly decreased, the glomerular filtration rate is significantly decreased, and the drug clearance ability is reduced, which will cause drug accumulation. In people with diabetes, a build-up of drugs can lead to kidney disease. Second, the enzyme activity of drug catabolism in the liver of the elderly is reduced, and it is also easy to accumulate drugs. Third, the ability of plasma proteins to bind drugs in the elderly decreases, the concentration of free drugs in the blood increases, and the application of small doses of drugs may cause some manifestations of young people's large doses. Fourth, the percentage of old people's body fat increases, lipophilic drugs are easy to accumulate in fat, and the incidence of adverse reactions will increase when multiple drugs are combined. Due to the large number of complications and drugs, the treatment compliance of the elderly is also poor. Therefore, it is necessary to choose some simple treatment methods for the elderly according to their characteristics to achieve the purpose of treatment.
u Application of insulin pump in elderly patients
The elderly can use insulin pumps, but in terms of application, it is necessary to pay attention to: first, the blood sugar control target value should not be set too low; Second, only elderly people with self-care ability, such as no visual impairment and certain operational ability, can use insulin pumps, which is a great challenge for elderly people, because elderly people may often have reduced vision and their ability to operate these modern instruments is also limited. However, clinically, there are still many elderly people who can use their own insulin pumps. For the elderly who use multiple daily insulin injections (MDI), the skilled use of insulin pumps can reduce a lot of burden, and many patients are willing to accept them. Most importantly, the incidence and severity of hypoglycemia were greatly reduced in patients treated with insulin pumps compared to MDI, which is very good for the elderly.
The use of dynamic blood glucose monitoring in the elderly may provide an even greater advantage. Blood glucose monitoring is a very important part of the "five wagons"; of diabetes treatment. Dynamic blood glucose monitoring is more important for elderly patients on insulin therapy because hypoglycemia can occur as long as insulin is used, and we can only minimize hypoglycemia. However, through dynamic blood glucose monitoring, the device will alarm when there is a trend of hypoglycemia, which can greatly reduce the occurrence of hypoglycemia in the elderly. In addition, the influence of different diets on blood sugar can be understood through dynamic blood glucose monitoring, and there are also many benefits to diet adjustment for the elderly. Therefore, the application of this technology can greatly improve the blood sugar control of diabetic patients and minimize the occurrence of hypoglycemia.